Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype

Teng Jian; Hejazi Seyedali; Hiddingh Lotte; Carvalho Litia; de Gooijer Mark; Wakimoto Hiroaki; Barazas Marco; Tannous Marie; Chi Andrew S.; Noske David P.; Wesseling Pieter; Wurdinger Thomas; Batchelor Tracy T.; Tannous Bakhos A.

首页> 外文期刊>Neuro-Oncology >Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype

【24h】

Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype

机译：勘误：回收药物筛选将羟基脲作为胶质母细胞瘤的敏化剂重新染色于替替替莫唑胺靶向de Novo DNA合成，而不论分子亚型如何

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neuro-Oncology》 |2020年第12期|1894-1894|共1页
作者
Teng Jian; Hejazi Seyedali; Hiddingh Lotte; Carvalho Litia; de Gooijer Mark; Wakimoto Hiroaki; Barazas Marco; Tannous Marie; Chi Andrew S.; Noske David P.; Wesseling Pieter; Wurdinger Thomas; Batchelor Tracy T.; Tannous Bakhos A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
入库时间 2022-08-18 23:31:59

相似文献

外文文献
专利

1. Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype [J] . Teng Jian, Hejazi Seyedali, Hiddingh Lotte, Neuro-Oncology . 2018,第5期

机译：回收药物筛查将羟基脲重新用作胶质母细胞瘤对靶向新生DNA合成的替莫唑胺的敏化剂，而与分子亚型无关
2. KML001, a Telomere-Targeting Drug, Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy and Radiotherapy through DNA Damage and Apoptosis [J] . Seon Rang Woo, Yunhee Ham, Wonyoung Kang, BioMed research international . 2014,第54期

机译：PIML001，一种端粒靶向药物，通过DNA损伤和细胞凋亡使胶质母细胞瘤细胞敏感到替莫唑胺化学疗法和放射疗法
3. KML001, a Telomere-Targeting Drug, Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy and Radiotherapy through DNA Damage and Apoptosis [J] . Seon RangWoo, YunheeHam, WonyoungKang, BioMed research international . 2014,第2期

机译：KML001，端粒靶向药物，通过DNA损伤和细胞凋亡使胶质母细胞瘤细胞对替莫唑胺化学疗法和放射疗法敏感。
4. Insilico screening of Prevotella Intermedia 17 identifies Lipopolysaccharide Biosynthesis Pathway genes as potential drug targets [C] . Nithya Mathivanan, G. Kiruthika, Rahavi Subashree 2016 International Conference on Bioinformatics and Systems Biology . 2016

机译：Prevotella Intermedia 17的硅胶筛选将脂多糖生物合成途径基因鉴定为潜在的药物靶标
5. Design, synthesis & evaluation of human Aurora kinase and phosphodiesterase inhibitors for anti-trypanosomal drug discovery via target repurposing. [D] . Ochiana, Stefan O. 2013

机译：设计，合成和评估人Aurora激酶和磷酸二酯酶抑制剂，通过靶标重新定位来抗锥虫药物。
6. Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis irrespective of molecular subtype [O] . Jian Teng, Seyedali Hejazi, Lotte Hiddingh, 2018

机译：回收药物筛查将羟基脲重新用作胶质母细胞瘤对靶向新生DNA合成的替莫唑胺的敏化剂而与分子亚型无关
7. Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype [O] . Jian Teng, Seyedali Hejazi, Lotte Hiddingh, 2017

机译：再循环药物筛选羟基脲作为胶质母细胞瘤的敏化剂，靶向De Novo DNA合成，而不是分子亚型

Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype

著录项

相似文献

相关主题

期刊订阅